annual cash & cash equivalents:
$11.97B+$1.03B(+9.40%)Summary
- As of today (August 22, 2025), AMGN annual cash & cash equivalents is $11.97 billion, with the most recent change of +$1.03 billion (+9.40%) on December 31, 2024.
- During the last 3 years, AMGN annual cash & cash equivalents has risen by +$3.98 billion (+49.87%).
- AMGN annual cash & cash equivalents is now at all-time high.
Performance
AMGN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$8.03B-$782.00M(-8.88%)Summary
- As of today (August 22, 2025), AMGN quarterly cash & cash equivalents is $8.03 billion, with the most recent change of -$782.00 million (-8.88%) on June 30, 2025.
- Over the past year, AMGN quarterly cash & cash equivalents has dropped by -$1.27 billion (-13.69%).
- AMGN quarterly cash & cash equivalents is now -80.74% below its all-time high of $41.68 billion, reached on December 31, 2017.
Performance
AMGN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMGN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | -13.7% |
| 3 y3 years | +49.9% | +11.8% |
| 5 y5 years | +98.3% | -29.7% |
AMGN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.9% | -76.9% | +11.8% |
| 5 y | 5-year | at high | +98.3% | -76.9% | +22.7% |
| alltime | all time | at high | >+9999.0% | -80.7% | >+9999.0% |
AMGN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $8.03B(-8.9%) |
| Mar 2025 | - | $8.81B(-26.4%) |
| Dec 2024 | $11.97B(+9.4%) | $11.97B(+32.9%) |
| Sep 2024 | - | $9.01B(-3.1%) |
| Jun 2024 | - | $9.30B(-4.2%) |
| Mar 2024 | - | $9.71B(-11.3%) |
| Dec 2023 | $10.94B(+43.5%) | $10.94B(-68.5%) |
| Sep 2023 | - | $34.74B(+1.4%) |
| Jun 2023 | - | $34.25B(+8.5%) |
| Mar 2023 | - | $31.56B(+239.2%) |
| Dec 2022 | $7.63B(-4.5%) | $9.30B(-18.9%) |
| Sep 2022 | - | $11.48B(+59.8%) |
| Jun 2022 | - | $7.18B(+9.8%) |
| Mar 2022 | - | $6.54B(-18.6%) |
| Dec 2021 | $7.99B(+27.5%) | $8.04B(-37.8%) |
| Sep 2021 | - | $12.92B(+59.9%) |
| Jun 2021 | - | $8.08B(-23.5%) |
| Mar 2021 | - | $10.57B(-0.8%) |
| Dec 2020 | $6.27B(+3.8%) | $10.65B(-13.9%) |
| Sep 2020 | - | $12.36B(+8.2%) |
| Jun 2020 | - | $11.42B(+42.5%) |
| Mar 2020 | - | $8.01B(-10.1%) |
| Dec 2019 | $6.04B(-13.1%) | $8.91B(-57.3%) |
| Sep 2019 | - | $20.85B(-4.2%) |
| Jun 2019 | - | $21.76B(-17.3%) |
| Mar 2019 | - | $26.30B(-10.2%) |
| Dec 2018 | $6.95B(+82.8%) | $29.30B(-2.1%) |
| Sep 2018 | - | $29.92B(+1.8%) |
| Jun 2018 | - | $29.39B(-8.6%) |
| Mar 2018 | - | $32.17B(-22.8%) |
| Dec 2017 | $3.80B(+17.2%) | $41.68B(+0.8%) |
| Sep 2017 | - | $41.35B(+5.4%) |
| Jun 2017 | - | $39.23B(+2.2%) |
| Mar 2017 | - | $38.40B(+0.8%) |
| Dec 2016 | $3.24B(-21.8%) | $38.09B(+0.3%) |
| Sep 2016 | - | $37.98B(+8.4%) |
| Jun 2016 | - | $35.03B(+0.8%) |
| Mar 2016 | - | $34.74B(+10.7%) |
| Dec 2015 | $4.14B(+11.1%) | $31.38B(+0.8%) |
| Sep 2015 | - | $31.12B(+3.8%) |
| Jun 2015 | - | $29.99B(+10.6%) |
| Mar 2015 | - | $27.12B(+0.3%) |
| Dec 2014 | $3.73B(-1.9%) | $27.03B(-3.7%) |
| Sep 2014 | - | $28.07B(+7.2%) |
| Jun 2014 | - | $26.19B(+32.2%) |
| Mar 2014 | - | $19.80B(+2.1%) |
| Dec 2013 | $3.81B(+16.8%) | $19.40B(-14.0%) |
| Sep 2013 | - | $22.56B(+2.5%) |
| Jun 2013 | - | $22.02B(+3.5%) |
| Mar 2013 | - | $21.27B(-11.6%) |
| Dec 2012 | $3.26B(-53.1%) | $24.06B(-5.2%) |
| Sep 2012 | - | $25.37B(+12.9%) |
| Jun 2012 | - | $22.48B(+16.0%) |
| Mar 2012 | - | $19.37B(-6.1%) |
| Dec 2011 | $6.95B(+111.3%) | $20.64B(+16.8%) |
| Sep 2011 | - | $17.68B(-7.8%) |
| Jun 2011 | - | $19.17B(+24.8%) |
| Mar 2011 | - | $15.36B(-11.8%) |
| Dec 2010 | $3.29B(+14.0%) | $17.42B(+2.2%) |
| Sep 2010 | - | $17.05B(+17.4%) |
| Jun 2010 | - | $14.52B(+2.9%) |
| Mar 2010 | - | $14.12B(+5.0%) |
| Dec 2009 | $2.88B(+62.6%) | $13.44B(-4.1%) |
| Sep 2009 | - | $14.01B(+17.1%) |
| Jun 2009 | - | $11.96B(+15.3%) |
| Mar 2009 | - | $10.38B(+8.6%) |
| Dec 2008 | $1.77B | $9.55B(-2.1%) |
| Sep 2008 | - | $9.76B(+15.0%) |
| Jun 2008 | - | $8.48B(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $8.65B(+20.9%) |
| Dec 2007 | $2.02B(+57.8%) | $7.15B(+20.2%) |
| Sep 2007 | - | $5.95B(+12.1%) |
| Jun 2007 | - | $5.31B(+9.7%) |
| Mar 2007 | - | $4.84B(-22.9%) |
| Dec 2006 | $1.28B(-30.3%) | $6.28B(+8.6%) |
| Sep 2006 | - | $5.78B(+16.3%) |
| Jun 2006 | - | $4.97B(-30.5%) |
| Mar 2006 | - | $7.15B(+36.0%) |
| Dec 2005 | $1.84B(+20.6%) | $5.25B(-5.3%) |
| Sep 2005 | - | $5.55B(+25.0%) |
| Jun 2005 | - | $4.44B(+10.0%) |
| Mar 2005 | - | $4.04B(+76.0%) |
| Dec 2004 | $1.53B(+82.3%) | - |
| Dec 2003 | $837.00M(-54.8%) | - |
| Dec 2002 | $1.85B(+168.8%) | - |
| Dec 2001 | $689.10M(+204.2%) | - |
| Mar 2001 | - | $2.29B(+22.8%) |
| Dec 2000 | $226.50M(+73.0%) | - |
| Sep 2000 | - | $1.87B(+15.2%) |
| Jun 2000 | - | $1.62B(+9.6%) |
| Mar 2000 | - | $1.48B(+8.1%) |
| Dec 1999 | $130.90M(-34.9%) | - |
| Jun 1999 | - | $1.37B(+3.8%) |
| Mar 1999 | - | $1.32B(+17.2%) |
| Dec 1998 | $201.10M(-15.9%) | - |
| Sep 1998 | - | $1.12B(+10.1%) |
| Jun 1998 | - | $1.02B(+16.0%) |
| Mar 1998 | - | $880.10M(+268.1%) |
| Dec 1997 | $239.10M(+41.2%) | $239.10M(-0.3%) |
| Sep 1997 | - | $239.90M(-27.5%) |
| Jun 1997 | - | $331.00M(+25.0%) |
| Mar 1997 | - | $264.80M(+56.4%) |
| Dec 1996 | $169.30M(+153.8%) | $169.30M(-25.4%) |
| Sep 1996 | - | $227.00M(+6.0%) |
| Jun 1996 | - | $214.20M(+243.3%) |
| Mar 1996 | - | $62.40M(-6.4%) |
| Dec 1995 | $66.70M(-68.4%) | $66.70M(-54.0%) |
| Sep 1995 | - | $145.00M(-25.6%) |
| Jun 1995 | - | $194.90M(-2.1%) |
| Mar 1995 | - | $199.00M(-5.8%) |
| Dec 1994 | $211.30M(+64.4%) | $211.30M(-29.9%) |
| Sep 1994 | - | $301.50M(+19.8%) |
| Jun 1994 | - | $251.60M(+70.3%) |
| Mar 1994 | - | $147.70M(+14.9%) |
| Dec 1993 | $128.50M(+39.7%) | $128.50M(-21.2%) |
| Sep 1993 | - | $163.00M(+19.6%) |
| Jun 1993 | - | $136.30M(+519.5%) |
| Mar 1993 | - | $22.00M(-76.1%) |
| Dec 1992 | $92.00M(-37.2%) | $92.00M(+43.8%) |
| Sep 1992 | - | $64.00M(-12.1%) |
| Jun 1992 | - | $72.80M(-48.0%) |
| Mar 1992 | - | $140.10M(-4.4%) |
| Dec 1991 | $146.50M(+273.7%) | $146.50M(+36.8%) |
| Sep 1991 | - | $107.10M(+37.8%) |
| Jun 1991 | - | $77.70M(+117.6%) |
| Mar 1991 | - | $35.70M(-35.3%) |
| Dec 1990 | - | $55.20M(+30.5%) |
| Sep 1990 | - | $42.30M(-48.2%) |
| Jun 1990 | - | $81.70M(+108.4%) |
| Mar 1990 | $39.20M(+89.4%) | $39.20M(+69.0%) |
| Dec 1989 | - | $23.20M(+75.8%) |
| Sep 1989 | - | $13.20M(-82.8%) |
| Jun 1989 | - | $76.80M(+271.0%) |
| Mar 1989 | $20.70M(-80.4%) | $20.70M(-80.4%) |
| Mar 1988 | $105.60M(+83.3%) | $105.60M(+83.3%) |
| Mar 1987 | $57.60M(-13.5%) | $57.60M(-13.5%) |
| Mar 1986 | $66.60M(+198.7%) | $66.60M(+198.7%) |
| Mar 1985 | $22.30M(-40.7%) | $22.30M(-40.7%) |
| Mar 1984 | $37.60M | $37.60M |
FAQ
- What is Amgen Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amgen Inc.?
- What is Amgen Inc. annual cash & cash equivalents year-on-year change?
- What is Amgen Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amgen Inc.?
- What is Amgen Inc. quarterly cash & cash equivalents year-on-year change?
What is Amgen Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AMGN is $11.97B
What is the all time high annual cash & cash equivalents for Amgen Inc.?
Amgen Inc. all-time high annual cash & cash equivalents is $11.97B
What is Amgen Inc. annual cash & cash equivalents year-on-year change?
Over the past year, AMGN annual cash & cash equivalents has changed by +$1.03B (+9.40%)
What is Amgen Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMGN is $8.03B
What is the all time high quarterly cash & cash equivalents for Amgen Inc.?
Amgen Inc. all-time high quarterly cash & cash equivalents is $41.68B
What is Amgen Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AMGN quarterly cash & cash equivalents has changed by -$1.27B (-13.69%)